πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda β€” grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≀24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months β€” use filters for patent-cliff planning.

Page 2 of 30

  1. US 12209138

    Anti-CD38 antibodies

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12202901

    Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid molecules thereof and methods of use thereof

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12202832

    Heterocyclic compounds having a calcium-sensing receptor antagonistic activity

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12202797

    Method for producing pyrrole compound

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12201683

    Methods for preventing dengue and hepatitis a

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12188948

    Metabolite biomarkers for diseases associated with the contact activation system

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12186313

    Pyridazinone compounds and their use as DAAO inhibitors

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12178981

    Drug administration method

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12178861

    Stabilized liquid and lyophilized ADAMTS13 formulations

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12171777

    Methods of making a cyclic dinucleotide

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12171832

    Methods of treating ulcerative colitis

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12168041

    Methods and compositions for CNS delivery of arylsulfatase A

    Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12162864

    Condensed-cyclic compound

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12161702

    Methods and compositions for CNS delivery of heparan N-sulfatase

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12156903

    Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12152027

    Heterocyclic compound

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12144809

    Treatment of prostate cancer

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12128090

    Methods of prophylactic treatment using recombinant VWF (rVWF)

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12128102

    Constrained conditionally activated binding proteins

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 12121569

    Methods and compositions for CNS delivery of iduronate-2-sulfatase

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 12122815

    GIP receptor agonist peptide compounds and uses thereof

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 12109260

    Zika vaccines and immunogenic compositions, and methods of using the same

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 12110343

    Anti-plasma kallikrein antibodies

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 12097306

    Conformal coating of biological surfaces

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 12097199

    Administration of SUMO-activating enzyme inhibitor and anti-CD20 antibodies

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 12097198

    Treatment of prostate cancer

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 12091675

    Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 12091410

    Heterocyclic compound

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 12084436

    Heterocyclic compound

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 12084431

    Pharmaceutical salts of pyrimidine derivatives and method of treating disorders

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 12084515

    Compositions and methods for treatment of diabetic macular edema

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 12077522

    Heterocyclic compound and application thereof

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 12071468

    Purification of Factor VIII subspecies

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 12071434

    Heterocyclic compound

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 12065448

    Heteroaryl plasma kallikrein inhibitors

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 12060382

    Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 Ξ²-L-ribofuranosyl)-1H-benzimidazole

    Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 12061206

    Diagnosis and treatment of autoimmune diseases

    Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 12053526

    Methods for treatment using anti-alpha4beta7 antibody

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 12054474

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 12048699

    Cancer treatment methods based on TP53 mutation status and hypermutation

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 12031130

    Composition for modifying target gene

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 12024505

    Heterocyclic compounds useful as modulators of acetylcholine receptors

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 12024512

    Cocrystal

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 12018052

    Methods of detection and removal of rhabdoviruses from cell lines

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 12018281

    Cardiomyocyte maturation promoter

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 12016904

    Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 12012419

    Heterocyclic compound

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 12005054

    Piperidinyl-3-(aryloxy)propanamides and propanoates

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.